
ZHAN Jia-hong,JIAN Wen-xuan,WAN Jiang-fan,et al
Online:2017-12-26Published:2017-12-01Contact:陈乃宏,男,教授,博士生导师;研究方向:神经系统疾患创新药物开发及作用机制;E-mail:chennh@imm.ac.cnAbout author:詹佳虹,女,硕士研究生;研究方向:神经药理学Supported by:
CLC Number:
ZHAN Jia-hong,JIAN Wen-xuan,WAN Jiang-fan,et al.The Research Progress of the Antioxidant Effect of Natural Compounds in the Treatment of Ischemic Stroke[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2017.06.009.
[1].Yang Jie, Cui Xiao-yang, Li Jie,et al.Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials[J]. Dev Neurorehabil, 2015, 18(5): 330-335.
[2].Wu Rong, Li Xiang-pen, Xu Peng-fei,et al.TREM2 protects against cerebral ischemia/reperfusion injury[J]. Mol Brain, 2017, 10(1): 20.
[3].Ain Neuhaus, Yvonne Couch, Gina Hadley,et al.Neuroprotection in stroke: the importance of collaboration and reproducibility[J]. Brain, 2017, 140(8): 2079-2092.
[4].Brouns R, P P De Deyn.The complexity of neurobiological processes in acute ischemic stroke[J]. Clin Neurol Neurosurg, 2009, 111(6): 483-495.
[5].Xu B, Wang T, Xiao J,et al. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3beta/ beta-catenin signaling pathway[J]. Biochem Pharmacol, 2019.
[6].赵薇,李方江,王树,脑缺血损伤保护作用机制研究进展[J].神经药理学报, 2014, 4(06): 55-63.
[7].Maja Steinlin.Neuroinflammation in ischemic pediatric stroke[J]. Semin Pediatr Neurol, 2017, 24(3): 201-206.
[8].Susan Randolph.Ischemic Stroke[J]. Workplace Health Saf, 2016, 64(9): 444.
[9].Idriss Ali Abdoulaye, Guo Yi-jing.A review of recent advances in neuroprotective potential of 3-N-Butylphthalide and its derivatives[J]. Biomed Res Int, 2016, 2016: 5012341.
[10]. S Manzanero, T Santro, T V Arumugam.Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury[J]. Neurochem Int, 2013, 62(5): 712-718.
[11].彭英,左旋丁基苯酞抗脑缺血和抗老年痴呆的药理作用及机制研究[D].北京:中国协和医科大学,2004.
[12]. Yan R Y, Wang S J, Yao G T,et al.The protective effect and its mechanism of 3-n-butylphthalide pretreatment on cerebral ischemia reperfusion injury in rats[J]. Eur Rev Med Pharmacol Sci, 2017, 21(22): 5275-5282.
[13]. Liu Run-zhe, Fan Chao-xin, Zhang Zhi-lin,et al.Effects of Dl-3-n-butylphthalide on cerebral ischemia infarction in rat model by mass spectrometry imaging[J]. Int J Mol Sci, 2017, 18(11): 2451.
[14].董高翔,冯亦璞.丁基苯酞对局部脑缺血再灌注大鼠脑线粒体ATPase,抗氧化酶活性和脂质过氧化的影响[J].中国医学科学院学报, 2002, 24(01): 93-97.
[15].种兆忠,冯亦璞.丁基苯酞对大脑中动脉阻断后皮层组织中花生四烯酸释放及磷脂酶A_2基因表达的影响(英文) [J].药学学报, 2000, 35(08): 561-565.
[16].杜冠华,张均田.丹参水溶性有效成分—丹酚酸研究进展[J].基础医学与临床, 2000, 20(05): 10-14.
[17].于金玲.丹酚酸B药理作用研究进展[J].天津药学, 2012, 24(03): 64-68.
[18]. Fan Yong, Luo Qian-ping, Wei Jing-jing,et al.Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury[J]. Brain Res, 2018, 1679: 125-133.
[19].赵莼.丹参多酚酸对脑缺血的药理研究进展[J].天津药学, 2018. 30(06): 53-57.
[20].何婷婷.丹酚酸B对局灶性脑缺血小鼠抑制自噬及凋亡机制的研究[J],石家庄:河北医科大学,2015.
[21].曾靖,黄志华,邱峰,等.大豆苷元耐缺氧的实验研究[J].中国现代应用药学, 2004, 21(06): 454-456.
[22].钟声,李泽玲,钟星明,等.大豆苷元对异丙肾上腺素所致心肌肥厚与抗氧化的影响[J].中国实验方剂学杂志, 2013, 19(09): 204-206.
[23]. Olivia Hurtado, Ivan Ballesteros, Maria Isabel Cuartero,et al.Daidzein has neuroprotective effects through ligand-binding-independent PPARgamma activation[J]. Neurochem Int, 2012, 61(1): 119-127.
[24]. Jessica M Stout, Austen N Knapp, William J Banz,et al.Subcutaneous daidzein administration enhances recovery of skilled ladder rung walking performance following stroke in rats[J]. Behav Brain Res, 2013, 256: 428-431.
[25]. Yuan Wa, Chen Qin, Zeng Jing,et al.3'-Daidzein sulfonate sodium improves mitochondrial functions after cerebral ischemia/reperfusion injury[J]. Neural Regen Res, 2017, 12(2): 235-241.
[26].刘梅,夏鑫华,张志敏,等.丹参素、原儿茶醛、咖啡酸和丹酚酸B体外抗氧化活性比较研究[J].中药材, 2009, 32(02): 265-267.
[27].张翠英,郭丽丽,王阶.原儿茶醛的药理研究进展[J].中国实验方剂学杂志, 2013, 19(23): 338-342.
[28]. Guo Chao, Wang Shi-quan, Duan Jia-lin,et al.Protocatechualdehyde protects against cerebral ischemia-reperfusion-induced oxidative injury via protein kinase Cepsilon/Nrf2/HO-1 pathway[J]. Mol Neurobiol, 2017, 54(2): 833-845.
[29]. Zheng Qing-hua, Li Xiao-li, Mei Zhi-gang,et al.Efficacy and safety of puerarin injection in curing acute ischemic stroke: A meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2017, 96(1): e5803.
[30]. Zhou Feng, Wang Liang, Liu Pan-pan,et al.Puerarin protects brain tissue against cerebral ischemia/reperfusion injury by inhibiting the inflammatory response[J]. Neural Regen Res, 2014, 9(23): 2074-2080.
[31]. Chang Yi, Cheng-Ying Hsieh, Peng Zi-Aa,et al.Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats[J]. J Biomed Sci, 2009, 16: 9.
[32].杨杰忠.葛根素的临床应用进展[J].中国医药指南, 2012, 10(21): 465-466.
[33].洪海棉.红景天苷激活PI3K/Akt/Nrf2信号通路对局灶性脑缺血大鼠的神经保护作用[J].福州:福建中医药大学, 2016.
[34].杨静静.基于PI3K/Akt信号通路探讨益母草碱对缺血脑卒中的神经保护作用机制[J].济南:山东中医药大学, 2016.
[35].王毅华.柚皮素对神经细胞糖氧剥夺/再灌注模型氧化应激作用影响的实验研究[J].南宁:广西中医药大学, 2018.
[36].郑红丽,李广生.山柰酚对缺血性脑损伤大鼠的神经保护作用研究[J].中风与神经疾病杂志, 2018, 35(10): 919-922.
|
| [1] | ZHAO Han-qing, FENG Peng-chao, ZHOU Li-fei, LI Li.Analysis of the Effect of Yigui Yufeng Decoction Combined with Acupuncture on the Curative Effect and Inflammatory Factor Level of Ischemic Strok[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 12-. |
| [2] | ZHU Jing-yi , FAN Jian-chun, YU Ai-mei.Research Status on the Neuroprotective Effect of Probucol[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 50-. |
| [3] | ZHOU Shu-yang, FU Xu-yang, SUN Yao, WU Wei, ZHAO Shu-ran, LIU Shuo, SHI Rui-li, HAO Xiao-qiong.Action Mechanism of Chemokine Action in Ischemic Stroke Based on GEO Database[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 1-7. |
| [4] | WANG Li-fei, LI Shu-rui.Meta-Analysis of the Clinical Efficacy of Edaravone in the Treatment of Ischaemic Stroke[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 8-15. |
| [5] | DONG Chuan-zhan, WANG Li-chun.Clinical Efficacy of Butylphthalide Combined with Sertraline in the Treatment of Post-stroke Depression and Its Effect on Inflammatory Factors[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(3): 10-14. |
| [6] | GUO Zixia, ZHANG Danshen.The Relationship Between Astrocytes and Ischemic Stroke[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(1): 18-23. |
| [7] | YUAN Xin-ru, ZHANG Dan-shen.Advances in Pharmacological Effects of Chrysophanol[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 34-40. |
| [8] | WENG Ying-hua.Effects of Atorvastatin Calcium on Nerve Function in Rats with Non-Cardiac Ischemic Stroke[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 13-17. |
| [9] | HAO Jun-rong, NIU Hong-shuang, LIU Yi-zhou, DONG Xiao-hua.Research Progress on the Role of Oxidative Stress in Diabetic Nephropathy and Its Antioxidant Treatment[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 33-38. |
| [10] | LIU Shan, LI Wei.Research Progress on Pharmacological Effects of L-theanine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 24-32. |
| [11] | PANG Xue-bo,XUE Qian,ZOU Yu-an.The Research Progress of Plasma Lipoprotein-associated Phospholipase A2 and Ischemic Stroke[J]. Acta Neuropharmacologica, 2017, 7(4): 31-35. |
| [12] | WANG Huan-huan, XUE Qian, ZOU Yu-an.Research Progress of the Mechanism of Endogenous Antioxidant Stress in Cerebral Ischemic Preconditioning and Ischemia Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2016, 6(2): 46-52. |
| [13] | FENG Xiao-ye,SONG Xiu-yun,CHEN Nai-hong.Research Progress of Peony Main Active Monomers on Cerebral Ischemia[J]. Acta Neuropharmacologica, 2016, 6(2): 37-45. |
| [14] | WANG Ying-ying, SONG Xiu-yun, WANG Qi, CHEN Nai-hong.Application of Natural Antioxidants in the Progress of Alzheimer's Disease[J]. Acta Neuropharmacologica, 2015, 5(6): 30-34. |
| [15] | LIU Song.Effects of Xingnaojing Injection on hs-CRP、IL-6 and TC in Patients with Acute Ischemic Stroke[J]. ACTA NEUROPHARMACOLOGICA, 2015, 5(5): 15-19. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||